Rapid Reversal of Novel Anticoagulant and Antiplatelet Medications in General Surgery Emergencies

Lisa L Schlitzkus, Jessica I. Summers, Paul J. Schenarts

Research output: Contribution to journalReview article

Abstract

The reversal of the new class of nonvitamin K antagonist oral anticoagulants (NOACs) is challenging in the emergent perioperative setting. This summary focuses on the reversal of NOACs, determining the emergent nature (risk analysis), and other considerations in reversal.

Original languageEnglish (US)
Pages (from-to)1073-1080
Number of pages8
JournalSurgical Clinics of North America
Volume98
Issue number5
DOIs
StatePublished - Oct 2018

Keywords

  • Emergent
  • Nonvitamin K antagonist oral anticoagulants
  • Perioperative management
  • Reversal agents
  • Urgent

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Rapid Reversal of Novel Anticoagulant and Antiplatelet Medications in General Surgery Emergencies'. Together they form a unique fingerprint.

  • Cite this